Sollie-Zetlmayer Hege Elisabeth bought PTCT
July 28, 2026 · Form 4 insider transaction
Sollie-Zetlmayer Hege Elisabeth bought 4,000 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 28, 2026
Filing dateJuly 30, 2026
Shares owned after50,526
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units granted on July 28, 2026, with the shares underlying such restricted stock units vesting in three equal annual installments, commencing on July 28, 2027.